💊 J&J halts Covid-19 vaccine production, Pfizer predicts another bumper year, Deloitte expands, BioSplice contracts, #HKhamsters report from the ether
Thank god it’s Wednesday. Which means only two more days to the weekend. And thinking about vaccine inequity. Which is covered in today’s issue. Along with news from the anti-aging space. And approvals and investments in and from India. And Deloitte applying healthcare learning to consumer services.


